As published on the NCSU Plants for Human Health website.
By Justin Moore, PHHI and NC Extension Communications
Peanuts are the leading cause of severe food allergic reactions in the U.S., with many restaurants, school systems and airlines completely removing the legume from their menus. In a step toward reducing the risk associated with peanut products, a team of scientists from North Carolina State University’s Plants for Human Health Institute has developed a food ingredient from peanut flour and cranberry extracts, among other plants, that has the potential to lessen the life-threatening allergic reactions brought on by peanut consumption.
A team of scientists in Dr. Mary Ann Lila’s lab at N.C. State’s Plants for Human Health Institute have developed a peanut-based flour that could lessen life-threatening allergic reactions to peanuts. Such a product might one day help people with allergies to develop a tolerance for peanuts. Dr. Mary Ann Lila, a lead researcher on the study with N.C. State’s Plants for Human Health Institute, notes that there’s no known cure for nut allergies, and they are on the rise.
A peanut allergy is a reaction that occurs when the body mistakenly identifies peanuts as harmful substances. The immune system – the body’s natural defense against infections and diseases – overreacts and can cause a serious or even life-threatening response ranging from mild itching and hives to anaphylactic shock, in which a person’s throat swells, making it difficult or impossible to breathe.
“Of the 170 foods that cause allergic reactions, peanuts can be the most dangerous,” said Lila. “Our research aim was to develop a clean, food-grade process that would result in a simpler, safer peanut ingredient to use in oral immunotherapy.”
Peanut allergies impact roughly 400,000 children in the U.S., where current immunotherapy treatments involve giving minute quantities of peanut proteins to patients over a period of time. This process, called “desensitization,” has been successful for some patients, but the milled roasted peanut flour that is currently used can also have severe side effects. Lila’s team set out to design a new type of edible flour that could help control food allergies without causing the dangerous reactions.
Researchers at N.C. State University’s Plants for Human Health Institute mixed peanut flour with extracts from a series of polyphenol-rich plants, like cranberries. The resulting flours have shown promise as safer peanut ingredients for immunotherapy treatments.
They turned to plant polyphenols, natural health-promoting chemicals found in plants like fruits and vegetables, which have shown promise as compounds that can alleviate allergic reactions. The scientists developed flours in which peanut proteins were bound with polyphenols from plants like black currant, cinnamon, cranberry and green tea – all of which seemed to make the peanut proteins less allergenic in lab tests.
The cranberry compounds-peanut flour combination is the only one to go to animal trials thus far, where it triggered the beneficial desensitization reactions without provoking harmful allergic responses in laboratory tests with mice. Lila and her team want to advance peanut flours with other plant extracts to animal and clinical trials in the future.
“This is an exciting discovery, and we’ll know a lot more about efficacy once clinical trials are done with peanut-allergic individuals,” said Lila. “We feel confident that the polyphenolic plant compounds make the peanut flour more hypoallergenic by masking or changing the allergy-inducing proteins, which is very promising.”
North Carolina ranks third in peanut production in the United States, but peanut allergies – which can have life-threatening side effects – are on the rise across the country.
Lila and her team plan to expand their work and create hypoallergenic food ingredients for other food allergies like eggs, soy and milk as soon as funding can be secured. Lila’s lab has utilized the same technology to developproduce-infused ingredients for foods in military ration packs.
The team of N.C. State scientists included Dr. Mary Ann Lila, Dr. Mary Grace and Nathalie Plundrich. In addition, researchers from the University of North Carolina at Chapel Hill and the U.S. Department of Agriculture co-authored the study, “Novel Strategy to Create Hypoallergenic Peanut Protein-Polyphenol Edible Matrices for Oral Immunotherapy,” which was published recently in the Journal of Agricultural and Food Chemistry.
Funding support was provided by the Everett W. Byrd Endowment and N.C. State University’s Plants for Human Health Institute at the N.C. Research Campus in Kannapolis.
About the Plants for Human Health Institute
The N.C. State University Plants for Human Health Institute is leading the discovery and delivery of innovative plant-based solutions to advance human health. N.C. Cooperative Extension serves as the outreach component of the institute, which is part of the N.C. Research Campus in Kannapolis. The campus is a public-private venture including eight universities, one community college, the David H. Murdock Research Institute (DHMRI) and corporate entities that collaborate to advance the fields of human health, nutrition and agriculture. Learn more at www.plantsforhumanhealth.ncsu.edu. Special thanks to the American Chemical Society (ACS), publisher of the Journal of Agricultural and Food Chemistry, who contributed to portions of this story.